Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
MEDIZONE INTERNATIONAL INC (MZEI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/19/2020 |
15-15D
| Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]: |
| 05/11/2018 |
8-K
| Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits |
| 04/25/2018 |
RW
| Form RW - Registration Withdrawal Request: |
| 04/24/2018 |
8-K
| Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o... |
| 04/17/2018 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/13/2018 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 04/06/2018 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/03/2018 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/27/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/22/2018 |
RW
| Form RW - Registration Withdrawal Request: |
| 03/20/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/02/2018 |
4
| Shannon Michael (PRESIDENT) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Disposed of 650,000 options to buy
@ $0.13, valued at
$84.5k
|
|
| 02/20/2018 |
4
| Caponi Vincent C (Director) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Acquired 750,000 options to buy
@ $0.0877, valued at
$65.8k
Acquired 1,000,000 options to buy
@ $0.1, valued at
$100k
|
|
| 02/16/2018 |
4
| Esposito David A (Director) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Disposed of 1,000,000 options to buy
@ $0.1095, valued at
$109.5k
Disposed of 750,000 options to buy
@ $0.0877, valued at
$65.8k
Disposed of 1,000,000 options to buy
@ $0.1, valued at
$100k
|
|
| 02/16/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/12/2018 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 02/05/2018 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a 8% convertible note of the Company, in the form attached hereto as Exhibit A , in the aggregate principal amount of US$152,500.00 issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Note”), convertible into shares of common stock, $0.001 par value per share, of the Company , upon the terms...",
"Securities Purchase Agreement, by and between the Company and SBI Investments LLC, 2014-1",
"Convertible Promissory Note, made by the Company in favor of L2 Capital, LLC",
"Convertible Promissory Note, made by the Company in favor of SBI Investments LLC, 2014-1",
"Common Stock Purchase Warrant, by and between the Company and L2 Capital LLC",
"Common Stock Purchase Warrant, by and between the Company and SBI Investments LLC, 2014-1",
"Equity Purchase Agreement, by and between the Company and the Investors",
"Registration Rights Agreement, by and between the Company and the Investors",
"Trading Agreement, by and between L2 Capital LLC and SBI Investments LLC, 2014-1",
"Medizone Announces Completion of Financing Kalamazoo, Michigan, January 31, 2018. Medizone International, Inc." |
|
| 02/01/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/18/2018 |
4
| Caponi Vincent C (Director) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Acquired 1,000,000 options to buy
@ $0.16, valued at
$160k
|
|
| 01/04/2018 |
4
| DODD DAVID A (CEO) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 01/04/2018 |
4
| THEODORE PHILIP A (Executive Vice President) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Disposed of 300,000 shares
@ $0 |
|
| 01/04/2018 |
4
| Sorensen Stephanie Lynn (CFO) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Acquired 250,000 options to buy
@ $0.1, valued at
$25k
|
|
| 01/02/2018 |
4
| Shannon Michael (PRESIDENT) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Disposed of 250,000 options to buy
@ $0.163, valued at
$40.8k
Disposed of 350,000 options to buy
@ $0.13, valued at
$45.5k
|
|
| 01/02/2018 |
4
| Esposito David A (Director) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Disposed of 1,000,000 options to buy
@ $0.1, valued at
$100k
|
|
| 12/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/30/2017 |
3
| THEODORE PHILIP A (Executive Vice President) has filed a Form 3 on MEDIZONE INTERNATIONAL INC |
| 11/08/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
| 11/03/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2017 |
8-K
| Quarterly results |
| 09/20/2017 |
4
| DODD DAVID A (CEO) has filed a Form 4 on MEDIZONE INTERNATIONAL INC|
Txns:
| Granted 1,000,000 shares
@ $0 |
|
| 09/19/2017 |
8-K
| Quarterly results |
| 09/19/2017 |
3
| DODD DAVID A (CEO) has filed a Form 3 on MEDIZONE INTERNATIONAL INC |
|
|
|